News & Events

Investors, Press Releases

The Board of Directors approves the net financial position for the first quarter of 2021

May 12, 2021

The Board of Directors approves the net financial position for the first quarter of 2021 in the amount of 104,668 thousand euro, and acknowledges the progress of the main clinical trials on Nidlegy™ and Fibromun in line with the expected timelines (Price Sensitive)

Last News & Events

Oct 2016 28

The European Commission (EC) has granted Orphan Drug Designation to L19TNF

Aug 2016 3

Philogen S.p.A. announced that they have entered into a collaboration, option and license agreement with Janssen Biotech

« Previous
1
…
101
102
103
104
105
…
108
Next »